ADVERUM BIOTECHNOLOGIES Design

View On IC.GC.CA

REGISTRATION PENDING

on 13 Nov 2024

Last Applicant/ Owned by

Adverum Biotechnologies, Inc.

100 Cardinal WayRedwood City, CA 94063

Serial Number

1964099 filed on 21^st May 2019

Registration Number

TMA1269216 registered on 13^th Nov 2024

Registration expiry Date

13^th Nov 2034

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

K1P5Y6

ADVERUM BIOTECHNOLOGIES Design

Trademark usage description

pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neuro Read More

Vienna Information

26 . 3 . 1

One triangleUn triangle

26 . 7 . 18

Triangles with linesTriangles avec lignes

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

Classification Information

Class [005]
Pharmaceutical preparations comprising recombinant adeno-associated virus for use in gene therapy for the treatment in humans of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of genetic diseases or disorders; pharmaceutical preparations comprising recombinant adeno-associated virus for use in the treatment in humans of gene therapy treatable diseases, namely, osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; pharmaceutical preparations comprising recombinant adeno-associated virus for gene therapy for the treatment in humans of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the ocular and auditory systems, and the genitourinary system

Classification kind code

Mark Details

Serial Number

1964099

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 15^th Jul 2024	Approved
Submitted for opposition 27 on 15^th Jul 2024	Approval Notice Sent
Submitted for opposition 22 on 9^th Jan 2024	Search Recorded
Submitted for opposition 20 on 9^th Jan 2024	Examiner's First Report
Submitted for opposition 67 on 29^th Sept 2023	Agent Name Changed
Submitted for opposition 135 on 27^th Feb 2023	Amendment to Application
Submitted for opposition 287 on 31^st May 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 24^th May 2019	Formalized
Submitted for opposition 1 on 22^nd May 2019	Created
Submitted for opposition 30 on 21^st May 2019	Filed